Early cancer diagnostics company developing non-invasive tests
| Date | Round | Amount |
|---|---|---|
| May 2023 | Funding round Cyted secured GBP13.4M co-led by BGF and Morningside Ventures, including a GBP3.4M NHS Cancer Programme grant, to expand its cancer diagnostics. | $16.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.